Literature DB >> 24481996

Epidemiology and etiopathogenesis of pituitary adenomas.

Elena D Aflorei1, Márta Korbonits.   

Abstract

Pituitary adenomas are usually benign monoclonal tumours presenting either due to hypersecretion of pituitary hormones, and/or due to local space occupying effects and hyposecretion of some or all of the pituitary hormones. Some pituitary adenomas cause prominent symptoms, while others may result in slowly developing, insidious, non-specific complains delaying accurate diagnosis, with a third group remaining symptomless and recognised only incidentally. Therefore, it is a challenge to accurately determine the prevalence and incidence of pituitary adenomas in the general population. The vast majority of pituitary adenomas occur sporadically, but familial cases are now increasingly recognised. Hereditary predisposition, somatic mutations and endocrine factors were shown to have a pathophysiologic role in the initiation and progression of pituitary adenomas, which interestingly almost always remain benign. Here, we summarize the available epidemiological data and the known pathogenesis of the pituitary adenomas.

Entities:  

Mesh:

Year:  2014        PMID: 24481996     DOI: 10.1007/s11060-013-1354-5

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  116 in total

1.  Incidence of pituitary adenomas in Northern Finland in 1992-2007.

Authors:  Antti Raappana; John Koivukangas; Tapani Ebeling; Tapio Pirilä
Journal:  J Clin Endocrinol Metab       Date:  2010-06-09       Impact factor: 5.958

2.  Abundance and state of phosphorylation of the retinoblastoma gene product in human pituitary tumors.

Authors:  M Woloschak; A Yu; J Xiao; K D Post
Journal:  Int J Cancer       Date:  1996-07-03       Impact factor: 7.396

3.  Functional and structural changes consequent to high dosages of radioactive iodine.

Authors:  A GORBMAN
Journal:  J Clin Endocrinol Metab       Date:  1950-10       Impact factor: 5.958

4.  Pituitary adenomas in Sweden between 1958 and 1991: incidence, survival, and mortality.

Authors:  B Nilsson; E Gustavasson-Kadaka; B A Bengtsson; B Jonsson
Journal:  J Clin Endocrinol Metab       Date:  2000-04       Impact factor: 5.958

5.  Modification of mortality and tumorigenesis by tocopherol-mono-glucoside (TMG) administered after X irradiation in mice and rats.

Authors:  Megumi Ueno; Hiroshi Inano; Makoto Onoda; Hironobu Murase; Nobuo Ikota; Tsutomu V Kagiya; Kazunori Anzai
Journal:  Radiat Res       Date:  2009-10       Impact factor: 2.841

6.  A double pituitary adenoma presenting as a prolactin-secreting tumor with partial response to medical therapy. Case report.

Authors:  Claire I Coiré; Harley S Smyth; Dominic Rosso; Eva Horvath; Kalman Kovacs
Journal:  Endocr Pathol       Date:  2010-06       Impact factor: 3.943

Review 7.  Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.

Authors:  Albert Beckers; Lauri A Aaltonen; Adrian F Daly; Auli Karhu
Journal:  Endocr Rev       Date:  2013-01-31       Impact factor: 19.871

8.  Incidental pituitary macroadenoma: a population-based study.

Authors:  G M Nammour; J Ybarra; M H Naheedy; J H Romeo; D C Aron
Journal:  Am J Med Sci       Date:  1997-11       Impact factor: 2.378

9.  Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK).

Authors:  Alberto Fernandez; Niki Karavitaki; John A H Wass
Journal:  Clin Endocrinol (Oxf)       Date:  2009-07-24       Impact factor: 3.478

10.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

View more
  52 in total

1.  Differential DNA methylome profiling of nonfunctioning pituitary adenomas suggesting tumour invasion is correlated with cell adhesion.

Authors:  Ye Gu; Xinyao Zhou; Fan Hu; Yong Yu; Tao Xie; Yuying Huang; Xinzhi Zhao; Xiaobiao Zhang
Journal:  J Neurooncol       Date:  2016-05-11       Impact factor: 4.130

2.  Identification of gene co-expression modules and hub genes associated with the invasiveness of pituitary adenoma.

Authors:  Yuancheng Zhou; Xiaorui Fu; Zhicheng Zheng; Yu Ren; Zijian Zheng; Bohan Zhang; Min Yuan; Jian Duan; Meihua Li; Tao Hong; Guohui Lu; Dongwei Zhou
Journal:  Endocrine       Date:  2020-04-27       Impact factor: 3.633

3.  Pituitary adenomas in elderly patients: clinical and surgical outcome analysis in a large series.

Authors:  Alfio Spina; Marco Losa; Pietro Mortini
Journal:  Endocrine       Date:  2019-06-17       Impact factor: 3.633

4.  Predicting early post-operative remission in pituitary adenomas: evaluation of the modified knosp classification.

Authors:  Marie Buchy; Véronique Lapras; Muriel Rabilloud; Alexandre Vasiljevic; Françoise Borson-Chazot; Emmanuel Jouanneau; Gérald Raverot
Journal:  Pituitary       Date:  2019-10       Impact factor: 4.107

5.  The expression profile of PD-L1 and CD8+ lymphocyte in pituitary adenomas indicating for immunotherapy.

Authors:  Peng-Fei Wang; Ting-Jian Wang; Ya-Kun Yang; Kun Yao; Zhuo Li; Yan Michael Li; Chang-Xiang Yan
Journal:  J Neurooncol       Date:  2018-04-21       Impact factor: 4.130

Review 6.  Common tools for pituitary adenomas research: cell lines and primary cells.

Authors:  Ziyan Zhu; Weiwei Cui; Dimin Zhu; Nailin Gao; Yonghong Zhu
Journal:  Pituitary       Date:  2020-04       Impact factor: 4.107

7.  Common variants at 10p12.31, 10q21.1 and 13q12.13 are associated with sporadic pituitary adenoma.

Authors:  Zhao Ye; Zhiqiang Li; Yongfei Wang; Ying Mao; Ming Shen; Qilin Zhang; Shiqi Li; Liangfu Zhou; Xuefei Shou; Jianhua Chen; Zhijian Song; Zengyi Ma; Zhaoyun Zhang; Yiming Li; Hongying Ye; Chuanxin Huang; Tao Wang; Wenqiang He; Yichao Zhang; Rong Xie; Nidan Qiao; Huijia Qiu; Shan Huang; Meng Wang; Jiawei Shen; Zujia Wen; Wenjin Li; Ke Liu; Juan Zhou; Lin Wang; Jue Ji; Yin Wang; Hong Chen; Haixia Cheng; Zhifeng Shi; Yuqian Zhu; Daoying Geng; Zhenwei Yao; Weijun Tang; Bin Lu; Li Pan; Yi Zhang; Weimin Bao; Jinsong Wu; Kang Zheng; Yongyong Shi; Yao Zhao
Journal:  Nat Genet       Date:  2015-06-01       Impact factor: 38.330

8.  The Role of p16 and MDM2 Gene Polymorphisms in Prolactinoma: MDM2 Gene Polymorphisms May Be Associated with Tumor Shrinkage.

Authors:  Seda Turgut; Muzaffer Ilhan; Saime Turan; Ozcan Karaman; Ilhan Yaylim; Ozlem Kucukhuseyin; Ertugrul Tasan
Journal:  In Vivo       Date:  2017 May-Jun       Impact factor: 2.155

9.  Oncogene-Induced Senescence in Pituitary Adenomas--an Immunohistochemical Study.

Authors:  Emilija Manojlovic-Gacic; Milica Skender-Gazibara; Vera Popovic; Ivan Soldatovic; Novica Boricic; Savo Raicevic; Sandra Pekic; Mirjana Doknic; Dragana Miljic; Irina Alafuzoff; Fredrik Pontén; Olivera Casar-Borota
Journal:  Endocr Pathol       Date:  2016-03       Impact factor: 3.943

Review 10.  Non-functioning pituitary adenomas: growth and aggressiveness.

Authors:  Kristin Astrid Øystese; Johan Arild Evang; Jens Bollerslev
Journal:  Endocrine       Date:  2016-04-11       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.